Please login or sign up to post and edit reviews.
Curing Cancer
Publisher |
Josh Kincaid
Media Type |
audio
Categories Via RSS |
Business
Business News
Investing
News
Publication Date |
Jul 19, 2022
Episode Duration |
00:27:22

Immunicom is developing a non-drug-based cancer therapy with the potential to reduce treatment side effects, enhance therapy response rates and improve cancer patients’ quality of life – all at significantly lower costs and without the side effects and complications prevalent in existing immunotherapy approaches. 

Immunicom's cancer therapy has the potential to allow the body’s natural immune system to directly attack the cancer while enhancing the effects of other cancer treatments. 

Episode 989 The #TalkingHedge interviews Ibrahim Basit of Immunicom...

https://youtu.be/G_ZpzJp97Jw

This episode currently has no reviews.

Submit Review
This episode could use a review!

This episode could use a review! Have anything to say about it? Share your thoughts using the button below.

Submit Review